GLS and non-small cell lung carcinoma: As yet another means of validating the utility of BPTES as a tool compound to screen for GLS dependence, we performed siRNA mediated knockdown of GLS1 (either total or GAC specifically) in a subset of 6 of the NSCLC lines from the panel.